{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:25:00Z","timestamp":1774056300825,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"S21","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Australian Research Council Future Fellowship","award":["FT170100047"],"award-info":[{"award-number":["FT170100047"]}]},{"name":"National Stem Cell Foundation of Australia","award":["Metcalf Prize"],"award-info":[{"award-number":["Metcalf Prize"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In genomics, we often assume that continuous data, such as gene expression, follow a specific kind of distribution. However we rarely stop to question the validity of this assumption, or consider how broadly applicable it may be to all genes that are in the transcriptome. Our study investigated the prevalence of a range of gene expression distributions in three different tumor types from the Cancer Genome Atlas (TCGA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Surprisingly, the expression of less than 50% of all genes was Normally-distributed, with other distributions including Gamma, Bimodal, Cauchy, and Lognormal also represented. Most of the distribution categories contained genes that were significantly enriched for unique biological processes. Different assumptions based on the shape of the expression profile were used to identify genes that could discriminate between patients with good versus poor survival. The prognostic marker genes that were identified when the shape of the distribution was accounted for reflected functional insights into cancer biology that were not observed when standard assumptions were applied. We showed that when multiple types of distributions were permitted, i.e. the shape of the expression profile was used, the statistical classifiers had greater predictive accuracy for determining the prognosis of a patient versus those that assumed only one type of gene expression distribution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results highlight the value of studying a gene\u2019s distribution shape to model heterogeneity of transcriptomic data and the impact on using analyses that permit more than one type of gene expression distribution. These insights would have been overlooked when using standard approaches that assume all genes follow the same type of distribution in a patient cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12859-020-03892-w","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T02:02:43Z","timestamp":1609120963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The shape of gene expression distributions matter: how incorporating distribution shape improves the interpretation of cancer transcriptomic data"],"prefix":"10.1186","volume":"21","author":[{"given":"Laurence","family":"de Torrent\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Christopeit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Greally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica C.","family":"Mar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,28]]},"reference":[{"issue":"22","key":"3892_CR1","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","unstructured":"Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368(22):2059\u201374.","journal-title":"N Engl J Med"},{"issue":"7353","key":"3892_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609\u201315.","journal-title":"Nature"},{"issue":"7216","key":"3892_CR3","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Cancer Genome Atlas Research Network","year":"2008","unstructured":"Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061\u20138.","journal-title":"Nature"},{"issue":"6","key":"3892_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1365-2141.2012.09091.x","volume":"157","author":"L Lim","year":"2012","unstructured":"Lim L, et al. Mature B-cell acute lymphoblastic leukaemia associated with a rare MLL-FOXO4 fusion gene. Br J Haematol. 2012;157(6):651.","journal-title":"Br J Haematol"},{"issue":"2","key":"3892_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1182\/blood-2002-06-1785","volume":"101","author":"CW So","year":"2003","unstructured":"So CW, Cleary ML. Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood. 2003;101(2):633\u20139.","journal-title":"Blood"},{"issue":"4","key":"3892_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ygeno.2013.06.004","volume":"102","author":"H Wang","year":"2013","unstructured":"Wang H, et al. Dynamic transcriptomes of human myeloid leukemia cells. Genomics. 2013;102(4):250\u20136.","journal-title":"Genomics"},{"issue":"16","key":"3892_CR7","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJMoa040465","volume":"350","author":"PJ Valk","year":"2004","unstructured":"Valk PJ, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med. 2004;350(16):1617\u201328.","journal-title":"N Engl J Med"},{"issue":"3","key":"3892_CR8","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1172\/JCI71264","volume":"124","author":"B Bartholdy","year":"2014","unstructured":"Bartholdy B, et al. HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia. J Clin Invest. 2014;124(3):1158\u201367.","journal-title":"J Clin Invest"},{"issue":"4","key":"3892_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1182\/blood-2010-09-191312","volume":"117","author":"G Marcucci","year":"2011","unstructured":"Marcucci G, et al. The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood. 2011;117(4):1121\u20139.","journal-title":"Blood"},{"issue":"24","key":"3892_CR10","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1001\/jama.2010.1862","volume":"304","author":"AJ Gentles","year":"2010","unstructured":"Gentles AJ, et al. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA. 2010;304(24):2706\u201315.","journal-title":"JAMA"},{"issue":"9","key":"3892_CR11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm.2415","volume":"17","author":"K Eppert","year":"2011","unstructured":"Eppert K, et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med. 2011;17(9):1086\u201393.","journal-title":"Nat Med"},{"issue":"9","key":"3892_CR12","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1200\/JCO.2012.44.3184","volume":"31","author":"Z Li","year":"2013","unstructured":"Li Z, et al. Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. J Clin Oncol. 2013;31(9):1172\u201381.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3892_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrc3932","volume":"15","author":"S Lin","year":"2015","unstructured":"Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15(6):321\u201333.","journal-title":"Nat Rev Cancer"},{"key":"3892_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fonc.2012.00033","volume":"2","author":"B Davidson","year":"2012","unstructured":"Davidson B, Trope CG, Reich R. Epithelial-mesenchymal transition in ovarian carcinoma. Front Oncol. 2012;2:33.","journal-title":"Front Oncol"},{"issue":"3","key":"3892_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1214\/08-AOAS169","volume":"2","author":"H Ishwaran","year":"2008","unstructured":"Ishwaran H, et al. Random survival forests. Ann Appl Stat. 2008;2(3):841\u201360.","journal-title":"Ann Appl Stat"},{"issue":"1","key":"3892_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12551-018-0494-4","volume":"11","author":"JC Mar","year":"2019","unstructured":"Mar JC. The rise of the distributions: why non-normality is important for understanding the transcriptome and beyond. Biophys Rev. 2019;11(1):89\u201394.","journal-title":"Biophys Rev"},{"key":"3892_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2164-9-3","volume":"9","author":"A Ertel","year":"2008","unstructured":"Ertel A, Tozeren A. Switch-like genes populate cell communication pathways and are enriched for extracellular proteins. BMC Genomics. 2008;9:3.","journal-title":"BMC Genomics"},{"issue":"3","key":"3892_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jmoldx.2012.01.007","volume":"14","author":"DN Kernagis","year":"2012","unstructured":"Kernagis DN, Hall AH, Datto MB. Genes with bimodal expression are robust diagnostic targets that define distinct subtypes of epithelial ovarian cancer with different overall survival. J Mol Diagn. 2012;14(3):214\u201322.","journal-title":"J Mol Diagn"},{"issue":"1","key":"3892_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejca.2011.06.025","volume":"48","author":"T Karn","year":"2012","unstructured":"Karn T, et al. Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation. Eur J Cancer. 2012;48(1):12\u201323.","journal-title":"Eur J Cancer"},{"issue":"7","key":"3892_CR20","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41416-019-0387-8","volume":"120","author":"DG Pique","year":"2019","unstructured":"Pique DG, et al. A novel approach to modelling transcriptional heterogeneity identifies the oncogene candidate CBX2 in invasive breast carcinoma. Br J Cancer. 2019;120(7):746\u201353.","journal-title":"Br J Cancer"},{"issue":"1","key":"3892_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/106652701300099074","volume":"8","author":"MA Newton","year":"2001","unstructured":"Newton MA, et al. On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. J Comput Biol. 2001;8(1):37\u201352.","journal-title":"J Comput Biol"},{"issue":"Suppl 24","key":"3892_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s12859-019-3252-0","volume":"20","author":"BV Church","year":"2019","unstructured":"Church BV, Williams HT, Mar JC. Investigating skewness to understand gene expression heterogeneity in large patient cohorts. BMC Bioinformatics. 2019;20(Suppl 24):668.","journal-title":"BMC Bioinformatics"},{"key":"3892_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2019.04.004","volume":"235\u2013236","author":"P Raman","year":"2019","unstructured":"Raman P, et al. A comparison of survival analysis methods for cancer gene expression RNA-Sequencing data. Cancer Genet. 2019;235\u2013236:1\u201312.","journal-title":"Cancer Genet"},{"key":"3892_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics"},{"issue":"3\/4","key":"3892_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2307\/2333709","volume":"52","author":"SS Shapiro","year":"1965","unstructured":"Shapiro SS, Wilk MB. An Analysis of Variance Test for Normality (Complete Samples). Biometrika. 1965;52(3\/4):591\u2013611.","journal-title":"Biometrika"},{"key":"3892_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1214\/aoms\/1177730256","volume":"19","author":"N Smirnov","year":"1948","unstructured":"Smirnov N. Table for estimating the goodness of fit of empirical distributions. Ann Math Stat. 1948;19:279\u201381.","journal-title":"Ann Math Stat"},{"issue":"318","key":"3892_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/01621459.1967.10482916","volume":"62","author":"HW Lilliefors","year":"1967","unstructured":"Lilliefors HW. On the Kolmogorov\u2013Smirnov test for normality with mean and variance unknown. J Am Stat Assoc. 1967;62(318):399\u2013402.","journal-title":"J Am Stat Assoc"},{"key":"3892_CR28","first-page":"199","volume":"7","author":"J Wang","year":"2009","unstructured":"Wang J, et al. The bimodality index: a criterion for discovering and ranking bimodal signatures from cancer gene expression profiling data. Cancer Inform. 2009;7:199\u2013216.","journal-title":"Cancer Inform"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-020-03892-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-020-03892-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-020-03892-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T14:02:57Z","timestamp":1609164177000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-020-03892-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"journal-issue":{"issue":"S21","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3892"],"URL":"https:\/\/doi.org\/10.1186\/s12859-020-03892-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/572693","asserted-by":"object"}]},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"17 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No permissions were required to use any of the repository data as all data used was publicly available.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"562"}}